Taxotere lawsuits claim the manufacturer of Taxotere (Sanofi-Aventis) failed to warn patients and physicians of the increased risks of permanent alopecia (loss of hair). Claims are being filed against Sanofi-Aventis by women who have suffered permanent hair loss as a result of being prescribed Taxotere. Our law firm is accepting clients who took Taxotere and suffered permanent hair loss.
Taxotere® (generic: docetaxel) is a chemotherapy drug prescribed primarily for the treatment of breast cancer. One of the side effects faced by patients treated with Taxotere® is permanent hair loss, a side effect that patients were never warned about. Sanofi-Aventis manufactured Taxotere®, an anti-cancer (“antineoplastic” or “cytotxic”) chemotherapy drug approved to treat breast cancer by the U.S. Food and Drug Administration (FDA) in 1996. Since its approval, it has also been approved to treat non-small cell lung cancer, advanced stomach cancer, head and neck cancer, and prostate cancer.
The most common and most severe side effect of Taxotere is permanent hair loss, also known as alopecia. Despite its effectiveness in treating cancer, recent studies have shown that approximately 9 percent of breast cancer patients who were prescribed and took Taxotere suffered from alopecia that lasted up to a decade or longer. It’s a well known fact that hair loss is a common side effect of chemotherapy, however, permanent hair loss is not. Other common side effects of Taxotere are listed as follows:
Breast cancer survivors who were treated with Taxotere are now suffering permanent hair loss, a side effect which the manufacturer did not disclose. The original Taxotere warning provided: “Once you have completed all your treatments, hair generally grows back.” This was a false claim. Lawsuits are now being filed against Sanofi-Aventis by women who have suffered permanent hair loss as a result of being prescribed Taxotere. Lawsuits allege that if the manufacturer had properly warned of the risks, patients would have been prescribed a different chemotherapy drug called Taxol, which is more effective than Taxotere, and does not result in permanent hair loss. All cases filed in federal court have been consolidated before one federal judge in New Orleans under a process known as multi-district litigation.
As of this time, there have been no large group settlements involving Taxotere and the potential link to permanent hair loss. Litigation like this takes many years to resolve, with teams of lawyers spending millions of dollars trying to determine exactly what occurred, and how it could have been prevented. However, our attorneys are currently investigating potential Taxotere lawsuits and are optimistic this litigation will provide justice to our clients. If you were treated with Taxotere and have suffered permanent hair loss following chemotherapy, you may be entitled to compensation. Contact My Vaccine Lawyer now to receive a free case evaluation at (800) 229-7704.
Page last reviewed and updated: November 20, 2019